Condition
Schizophrenia and Schizophrenia Spectrum Psychosis
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 6 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
6 shownNorwegian Mental Illness Heart Health StudyNCT07085923 · 2025-09-16
RECRUITINGInvestigation of Using Non-Wearable Devices to Assess Sleep- Disordered Breathing in Hospitalized Patients With SchizophreniaNCT07192042 · 2025-09-09
RECRUITINGFeeling Safe StudyNCT07234708 · 2025-07-01
RECRUITINGEffects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use DisorderNCT06939088 · 2025-05-05
RECRUITINGObsessive-Compulsive Disorder: Insight, Trauma, and Links to Schizophrenia Spectrum DisordersNCT07092826 · 2023-02-01
ACTIVE_NOT_RECRUITINGModafinil as an Adjunctive on Cognitive Functioning in Patients With SchizophreniaNCT00314639 · 2005-09-01
COMPLETEDCommon interventions
Leading sponsors
Trial status mix
RECRUITING4
ACTIVE_NOT_RECRUITING1
COMPLETED1
Phase mix
NA2
PHASE22
PHASE11
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.